Tamsulosin
Flomax
- User: Male
- Hormonal: Non-Hormonal
-
Delivery type:
- Oral
-
Intended Duration:
- Pericoital
- Development Stage: Pre-Clinical
- Developer(s)/researcher(s): Centro Universitario FMABC
Details
- API: Tamsulosin
- Target: Adrenoceptor
-
Mechanism of Action:
- Inhibition of Sperm Motility
- Other
- Inactive Materials: Not Yet Determined
- Regimen: Not Yet Determined
- MPT: Not Potential MPT
- Promising Attributes: Tamsulosin has SRA approval for other indications. It may offer an on-demand option to male users with a desirable safety and side effect profile.
Product Status
Developer Confirms Active Research
History
Tamsulosin is an FDA-approved product (marketed as Flomax) used to treat benign prostatic hyperplasia. It was briefly evaluated for a contraceptive indication, including small scale human studies. Centro Universitario FMABC confirmed active evaluation in 2023.